Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-19-007947)

Filing Details

Accession Number:: 0001493152-19-007947
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-20 18:38:49
Reporting Period:: 2019-05-16

Accepted Time:: 2019-05-20 18:38:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1582554	Matinas Biopharma Holdings Inc.	MTNB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218815	J Herbert Conrad	C/O Matinas Biopharma Holdings, Inc. 1545 Route 206 South Suite 302 Bedminster NJ 07921		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2019-05-16	25,000	$0.96	172,959	No	4	P	Indirect	By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Herbert J. Conrad Trust u/a/d 3/4/2005, Herbert J Conrad and Judith Conrad, Trustees

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	122,019	Direct
Common Stock, Par Value $0.0001 Per Share	3,784,944	Indirect	Herbert Conrad 2019 Grantor Retained Annuity Trust (GRAT)

Footnotes

The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9563 to $0.9650, inclusive. Upon request of the SEC staff, the reporting person will provide full information regarding the number of shares purchased at each separate price.